Tech-Enabled Chronic Care (TECC) FHIR IG
0.1.0 - ci-build
Tech-Enabled Chronic Care (TECC) FHIR IG - Local Development build (v0.1.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
| Draft as of 2025-12-08 |
{
"resourceType" : "ValueSet",
"id" : "sglt2-medications",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ValueSet sglt2-medications</b></p><a name=\"sglt2-medications\"> </a><a name=\"hcsglt2-medications\"> </a><ul><li>Include these codes as defined in <a href=\"http://www.nlm.nih.gov/research/umls/rxnorm\"><code>http://www.nlm.nih.gov/research/umls/rxnorm</code></a><span title=\"Version is not explicitly stated. No matching Code System found\"> version Not Stated (use latest from terminology server)</span><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>1481660</td><td>Empagliflozin 10 MG</td></tr></table></li></ul></div>"
},
"url" : "https://tecc.dev/fhir/ValueSet/sglt2",
"version" : "0.1.0",
"name" : "SGLT2Medications",
"title" : "SGLT2 Inhibitors",
"status" : "draft",
"date" : "2025-12-08T17:13:31+00:00",
"publisher" : "tecc",
"contact" : [
{
"name" : "tecc",
"telecom" : [
{
"system" : "url",
"value" : "https://tecc.dev"
}
]
}
],
"description" : "SGLT2 medications applicable across diabetes and CKD outcomes.",
"compose" : {
"include" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"concept" : [
{
"code" : "1481660",
"display" : "Empagliflozin 10 MG"
}
]
}
]
}
}